

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle fiber development (GO:0048741) | 8.27081109 |
| 2 | actin filament-based movement (GO:0030048) | 8.05874723 |
| 3 | plasma membrane repair (GO:0001778) | 7.12054389 |
| 4 | myotube cell development (GO:0014904) | 7.08029129 |
| 5 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.07043951 |
| 6 | glycogen catabolic process (GO:0005980) | 6.94841662 |
| 7 | striated muscle contraction (GO:0006941) | 6.81571186 |
| 8 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.59423064 |
| 9 | sarcomere organization (GO:0045214) | 6.57742962 |
| 10 | skeletal muscle tissue regeneration (GO:0043403) | 6.56323434 |
| 11 | glucan catabolic process (GO:0009251) | 6.50914551 |
| 12 | creatine metabolic process (GO:0006600) | 6.48641974 |
| 13 | purine nucleotide salvage (GO:0032261) | 6.15699650 |
| 14 | cellular polysaccharide catabolic process (GO:0044247) | 6.07787691 |
| 15 | striated muscle atrophy (GO:0014891) | 6.02935263 |
| 16 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.00808709 |
| 17 | carnitine shuttle (GO:0006853) | 6.00760858 |
| 18 | response to muscle activity (GO:0014850) | 5.83534040 |
| 19 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.81774886 |
| 20 | polysaccharide catabolic process (GO:0000272) | 5.81766547 |
| 21 | cytidine catabolic process (GO:0006216) | 5.74265758 |
| 22 | cytidine deamination (GO:0009972) | 5.74265758 |
| 23 | cytidine metabolic process (GO:0046087) | 5.74265758 |
| 24 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.70993321 |
| 25 | regulation of cell communication by electrical coupling (GO:0010649) | 5.68131119 |
| 26 | muscle contraction (GO:0006936) | 5.64079841 |
| 27 | response to inactivity (GO:0014854) | 5.61142279 |
| 28 | striated muscle adaptation (GO:0014888) | 5.31984172 |
| 29 | IMP metabolic process (GO:0046040) | 5.26664782 |
| 30 | glycogen biosynthetic process (GO:0005978) | 5.25014993 |
| 31 | glucan biosynthetic process (GO:0009250) | 5.25014993 |
| 32 | muscle atrophy (GO:0014889) | 5.24650259 |
| 33 | fatty acid transmembrane transport (GO:1902001) | 5.05387094 |
| 34 | muscle system process (GO:0003012) | 5.01747260 |
| 35 | muscle fiber development (GO:0048747) | 5.00345795 |
| 36 | NADH metabolic process (GO:0006734) | 4.98238512 |
| 37 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.79707285 |
| 38 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.76459846 |
| 39 | cardiac muscle hypertrophy (GO:0003300) | 4.62044828 |
| 40 | glycogen metabolic process (GO:0005977) | 4.61062658 |
| 41 | glucan metabolic process (GO:0044042) | 4.51902268 |
| 42 | cellular glucan metabolic process (GO:0006073) | 4.51902268 |
| 43 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.49996201 |
| 44 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.44609869 |
| 45 | carnitine transmembrane transport (GO:1902603) | 4.44496088 |
| 46 | striated muscle hypertrophy (GO:0014897) | 4.41053531 |
| 47 | fructose metabolic process (GO:0006000) | 4.33978141 |
| 48 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.33852389 |
| 49 | * myofibril assembly (GO:0030239) | 4.33830836 |
| 50 | muscle adaptation (GO:0043500) | 4.31820037 |
| 51 | neuronal action potential propagation (GO:0019227) | 4.20605108 |
| 52 | negative regulation of muscle hypertrophy (GO:0014741) | 4.18556173 |
| 53 | muscle cell fate commitment (GO:0042693) | 4.18555546 |
| 54 | negative regulation of skeletal muscle tissue development (GO:0048642) | 4.14197675 |
| 55 | muscle organ morphogenesis (GO:0048644) | 4.12849181 |
| 56 | 2-oxoglutarate metabolic process (GO:0006103) | 4.10921929 |
| 57 | IMP biosynthetic process (GO:0006188) | 4.08114343 |
| 58 | amino-acid betaine transport (GO:0015838) | 4.05783009 |
| 59 | carnitine transport (GO:0015879) | 4.05783009 |
| 60 | response to activity (GO:0014823) | 4.04224522 |
| 61 | regulation of skeletal muscle cell differentiation (GO:2001014) | 4.04190108 |
| 62 | * actomyosin structure organization (GO:0031032) | 4.03675714 |
| 63 | regulation of relaxation of muscle (GO:1901077) | 4.02268677 |
| 64 | gluconeogenesis (GO:0006094) | 3.98182709 |
| 65 | muscle hypertrophy (GO:0014896) | 3.95270282 |
| 66 | cardiac muscle contraction (GO:0060048) | 3.92965405 |
| 67 | regulation of cofactor metabolic process (GO:0051193) | 3.92836314 |
| 68 | regulation of coenzyme metabolic process (GO:0051196) | 3.92836314 |
| 69 | cellular carbohydrate catabolic process (GO:0044275) | 3.89407787 |
| 70 | muscle tissue morphogenesis (GO:0060415) | 3.88602784 |
| 71 | muscle organ development (GO:0007517) | 3.85736235 |
| 72 | cellular response to dexamethasone stimulus (GO:0071549) | 3.84245821 |
| 73 | muscle cell cellular homeostasis (GO:0046716) | 3.83129776 |
| 74 | muscle structure development (GO:0061061) | 3.80759910 |
| 75 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.77519076 |
| 76 | neuromuscular synaptic transmission (GO:0007274) | 3.75527719 |
| 77 | striated muscle cell development (GO:0055002) | 3.72346006 |
| 78 | adult heart development (GO:0007512) | 3.71247324 |
| 79 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.65122287 |
| 80 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.60318538 |
| 81 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.60318538 |
| 82 | myotube differentiation (GO:0014902) | 3.60204751 |
| 83 | response to dexamethasone (GO:0071548) | 3.58398037 |
| 84 | hexose biosynthetic process (GO:0019319) | 3.55971715 |
| 85 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.55439526 |
| 86 | skeletal muscle tissue development (GO:0007519) | 3.54134533 |
| 87 | tricarboxylic acid cycle (GO:0006099) | 3.50367921 |
| 88 | negative regulation of muscle contraction (GO:0045932) | 3.49685933 |
| 89 | cardiac muscle cell development (GO:0055013) | 3.48016925 |
| 90 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.44136811 |
| 91 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.44136811 |
| 92 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.42333340 |
| 93 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.41482213 |
| 94 | muscle hypertrophy in response to stress (GO:0003299) | 3.41482213 |
| 95 | cardiac muscle adaptation (GO:0014887) | 3.41482213 |
| 96 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.39706996 |
| 97 | striated muscle tissue development (GO:0014706) | 3.39046463 |
| 98 | heart process (GO:0003015) | 3.35110054 |
| 99 | heart contraction (GO:0060047) | 3.35110054 |
| 100 | regulation of striated muscle contraction (GO:0006942) | 3.31417240 |
| 101 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.31390555 |
| 102 | ubiquinone biosynthetic process (GO:0006744) | 3.30281866 |
| 103 | positive regulation of myotube differentiation (GO:0010831) | 3.29740256 |
| 104 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.27296263 |
| 105 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.26957192 |
| 106 | myoblast fusion (GO:0007520) | 3.26148386 |
| 107 | cellular polysaccharide metabolic process (GO:0044264) | 3.24637935 |
| 108 | cardiac cell development (GO:0055006) | 3.22305094 |
| 109 | relaxation of muscle (GO:0090075) | 3.22007501 |
| 110 | positive regulation of cation channel activity (GO:2001259) | 3.20587271 |
| 111 | regulation of sulfur metabolic process (GO:0042762) | 3.19234400 |
| 112 | regulation of actin filament-based movement (GO:1903115) | 3.17293497 |
| 113 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.17272166 |
| 114 | muscle cell development (GO:0055001) | 3.16947658 |
| 115 | cardiac myofibril assembly (GO:0055003) | 3.13913590 |
| 116 | positive regulation of myoblast differentiation (GO:0045663) | 3.13648164 |
| 117 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.12313004 |
| 118 | cellular polysaccharide biosynthetic process (GO:0033692) | 3.11540169 |
| 119 | neuromuscular junction development (GO:0007528) | 3.08221083 |
| 120 | polysaccharide biosynthetic process (GO:0000271) | 3.06532008 |
| 121 | regulation of myoblast differentiation (GO:0045661) | 3.00752854 |
| 122 | muscle filament sliding (GO:0030049) | 13.1763294 |
| 123 | actin-myosin filament sliding (GO:0033275) | 13.1763294 |
| 124 | regulation of skeletal muscle contraction (GO:0014819) | 12.8222461 |
| 125 | skeletal muscle contraction (GO:0003009) | 11.5011532 |
| 126 | actin-mediated cell contraction (GO:0070252) | 10.7875679 |
| 127 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.5741948 |
| 128 | skeletal muscle adaptation (GO:0043501) | 10.2435953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 9.50994243 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.45413764 |
| 3 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.49241076 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.42390473 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.28199103 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.25918217 |
| 7 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.80577773 |
| 8 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.46203496 |
| 9 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.44702183 |
| 10 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.44702183 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.44149178 |
| 12 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.38094087 |
| 13 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.35576344 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.20978214 |
| 15 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.19598974 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.04936247 |
| 17 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.84232252 |
| 18 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.83495346 |
| 19 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.81948292 |
| 20 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.75056875 |
| 21 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.71622819 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.71301181 |
| 23 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.70892847 |
| 24 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.68769826 |
| 25 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.63279627 |
| 26 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.62476043 |
| 27 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.57682287 |
| 28 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.54783756 |
| 29 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.48772882 |
| 30 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.47676542 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47627153 |
| 32 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.42781167 |
| 33 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.41282871 |
| 34 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.40089586 |
| 35 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.38812468 |
| 36 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.37142302 |
| 37 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.35896379 |
| 38 | SA1_27219007_Chip-Seq_Bcells_Human | 1.34094703 |
| 39 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.32924752 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.30877401 |
| 41 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.26765093 |
| 42 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.26740288 |
| 43 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.26633295 |
| 44 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.24966492 |
| 45 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.24409540 |
| 46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21791762 |
| 47 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.20568753 |
| 48 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.19588450 |
| 49 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.18565770 |
| 50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.15486224 |
| 51 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.14387140 |
| 52 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.13265367 |
| 53 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.13265367 |
| 54 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.12882553 |
| 55 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 1.10460496 |
| 56 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.10246099 |
| 57 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.07415196 |
| 58 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.07104429 |
| 59 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.06764533 |
| 60 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.06683296 |
| 61 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06272603 |
| 62 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.05967321 |
| 63 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05947625 |
| 64 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.05811570 |
| 65 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05654829 |
| 66 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.04327999 |
| 67 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03574585 |
| 68 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.03289107 |
| 69 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.02692586 |
| 70 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.02469124 |
| 71 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.02448936 |
| 72 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.02411603 |
| 73 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02314341 |
| 74 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.01094132 |
| 75 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.99726803 |
| 76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.99686225 |
| 77 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.98435577 |
| 78 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.98282408 |
| 79 | P68_20966046_ChIP-Seq_HELA_Human | 0.98139258 |
| 80 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97604748 |
| 81 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.97193213 |
| 82 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.96826422 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96029169 |
| 84 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.95549612 |
| 85 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95240033 |
| 86 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.94603233 |
| 87 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94314642 |
| 88 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94124749 |
| 89 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93975217 |
| 90 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.93398624 |
| 91 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91941221 |
| 92 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.91889071 |
| 93 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.91855858 |
| 94 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.90913462 |
| 95 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.90587141 |
| 96 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89615858 |
| 97 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.89151395 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88940494 |
| 99 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.88720163 |
| 100 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.88491089 |
| 101 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.88394535 |
| 102 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.88141844 |
| 103 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87880773 |
| 104 | CJUN_26792858_Chip-Seq_BT549_Human | 0.87361933 |
| 105 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.86307858 |
| 106 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.86278818 |
| 107 | ATF3_27146783_Chip-Seq_COLON_Human | 0.86036291 |
| 108 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85807804 |
| 109 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.85666029 |
| 110 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.85381891 |
| 111 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.85365779 |
| 112 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.85179593 |
| 113 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.84958954 |
| 114 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.84717383 |
| 115 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.84704478 |
| 116 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.84556518 |
| 117 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.83292277 |
| 118 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.83171889 |
| 119 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.83089027 |
| 120 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82709473 |
| 121 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82360953 |
| 122 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.82283537 |
| 123 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.82044422 |
| 124 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.81938030 |
| 125 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.81039691 |
| 126 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.80436488 |
| 127 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.80326457 |
| 128 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80069059 |
| 129 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80069059 |
| 130 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79663716 |
| 131 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79037918 |
| 132 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.75904940 |
| 133 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.75792997 |
| 134 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.73596812 |
| 135 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72750180 |
| 136 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.71070529 |
| 137 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.70287288 |
| 138 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.69786489 |
| 139 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.69038227 |
| 140 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.68917385 |
| 141 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.68337629 |
| 142 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.67955722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 8.50267799 |
| 2 | MP0003646_muscle_fatigue | 6.55601727 |
| 3 | MP0000751_myopathy | 5.80471594 |
| 4 | * MP0000749_muscle_degeneration | 5.78493872 |
| 5 | MP0000747_muscle_weakness | 4.70696613 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.22579648 |
| 7 | * MP0002106_abnormal_muscle_physiology | 4.21697056 |
| 8 | * MP0000759_abnormal_skeletal_muscle | 3.85724386 |
| 9 | MP0002269_muscular_atrophy | 3.71570608 |
| 10 | * MP0005369_muscle_phenotype | 3.51990109 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 3.46462016 |
| 12 | MP0004130_abnormal_muscle_cell | 3.46243964 |
| 13 | * MP0004087_abnormal_muscle_fiber | 3.37742719 |
| 14 | MP0005620_abnormal_muscle_contractility | 3.29151327 |
| 15 | MP0004233_abnormal_muscle_weight | 2.75261378 |
| 16 | MP0000733_abnormal_muscle_development | 2.44710090 |
| 17 | * MP0000750_abnormal_muscle_regeneration | 2.26495436 |
| 18 | MP0002108_abnormal_muscle_morphology | 2.12776832 |
| 19 | MP0006036_abnormal_mitochondrial_physio | 1.98327484 |
| 20 | MP0005330_cardiomyopathy | 1.90790228 |
| 21 | MP0004185_abnormal_adipocyte_glucose | 1.80586673 |
| 22 | MP0004084_abnormal_cardiac_muscle | 1.65514345 |
| 23 | MP0002971_abnormal_brown_adipose | 1.42712711 |
| 24 | MP0005666_abnormal_adipose_tissue | 1.41974627 |
| 25 | MP0004270_analgesia | 1.38881540 |
| 26 | MP0002972_abnormal_cardiac_muscle | 1.30923792 |
| 27 | MP0004484_altered_response_of | 1.27295670 |
| 28 | MP0004215_abnormal_myocardial_fiber | 1.26979381 |
| 29 | MP0003806_abnormal_nucleotide_metabolis | 1.26815860 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.21754696 |
| 31 | MP0010630_abnormal_cardiac_muscle | 1.20355569 |
| 32 | * MP0002332_abnormal_exercise_endurance | 1.11613400 |
| 33 | MP0005275_abnormal_skin_tensile | 1.09841078 |
| 34 | MP0001661_extended_life_span | 1.09496833 |
| 35 | MP0005375_adipose_tissue_phenotype | 1.05998654 |
| 36 | MP0003950_abnormal_plasma_membrane | 1.05007750 |
| 37 | MP0000013_abnormal_adipose_tissue | 1.03597567 |
| 38 | MP0006035_abnormal_mitochondrial_morpho | 1.03325496 |
| 39 | MP0002822_catalepsy | 1.03054097 |
| 40 | MP0003705_abnormal_hypodermis_morpholog | 1.01062811 |
| 41 | MP0004134_abnormal_chest_morphology | 0.96273080 |
| 42 | MP0005385_cardiovascular_system_phenoty | 0.87395942 |
| 43 | MP0001544_abnormal_cardiovascular_syste | 0.87395942 |
| 44 | MP0000372_irregular_coat_pigmentation | 0.82908060 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 0.82119489 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 0.78423366 |
| 47 | MP0004147_increased_porphyrin_level | 0.77366020 |
| 48 | MP0009250_abnormal_appendicular_skeleto | 0.76598071 |
| 49 | MP0002234_abnormal_pharynx_morphology | 0.72755323 |
| 50 | MP0000762_abnormal_tongue_morphology | 0.71882959 |
| 51 | MP0001299_abnormal_eye_distance/ | 0.71230168 |
| 52 | MP0003137_abnormal_impulse_conducting | 0.70546292 |
| 53 | MP0008961_abnormal_basal_metabolism | 0.68625608 |
| 54 | MP0004043_abnormal_pH_regulation | 0.67413844 |
| 55 | MP0005334_abnormal_fat_pad | 0.65832291 |
| 56 | * MP0005266_abnormal_metabolism | 0.64505806 |
| 57 | MP0003879_abnormal_hair_cell | 0.63462407 |
| 58 | MP0002078_abnormal_glucose_homeostasis | 0.62500962 |
| 59 | MP0000003_abnormal_adipose_tissue | 0.57499001 |
| 60 | MP0000343_altered_response_to | 0.55634765 |
| 61 | MP0005670_abnormal_white_adipose | 0.55340390 |
| 62 | MP0002127_abnormal_cardiovascular_syste | 0.54852890 |
| 63 | MP0008775_abnormal_heart_ventricle | 0.54337041 |
| 64 | MP0000266_abnormal_heart_morphology | 0.53914215 |
| 65 | MP0002089_abnormal_postnatal_growth/wei | 0.52834403 |
| 66 | MP0010030_abnormal_orbit_morphology | 0.51653653 |
| 67 | MP0005083_abnormal_biliary_tract | 0.49194015 |
| 68 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.48598247 |
| 69 | MP0005452_abnormal_adipose_tissue | 0.48471022 |
| 70 | MP0002896_abnormal_bone_mineralization | 0.47558174 |
| 71 | MP0003959_abnormal_lean_body | 0.46774489 |
| 72 | MP0008569_lethality_at_weaning | 0.45262703 |
| 73 | MP0003045_fibrosis | 0.44102205 |
| 74 | MP0001346_abnormal_lacrimal_gland | 0.43768602 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 0.43601354 |
| 76 | MP0009672_abnormal_birth_weight | 0.43511772 |
| 77 | MP0002796_impaired_skin_barrier | 0.43238320 |
| 78 | MP0000579_abnormal_nail_morphology | 0.41616829 |
| 79 | MP0002638_abnormal_pupillary_reflex | 0.40018876 |
| 80 | MP0001243_abnormal_dermal_layer | 0.37340748 |
| 81 | MP0002114_abnormal_axial_skeleton | 0.37092254 |
| 82 | MP0004510_myositis | 0.35443097 |
| 83 | MP0000383_abnormal_hair_follicle | 0.35433033 |
| 84 | MP0001849_ear_inflammation | 0.35421576 |
| 85 | MP0006138_congestive_heart_failure | 0.35226287 |
| 86 | MP0002734_abnormal_mechanical_nocicepti | 0.35131847 |
| 87 | MP0005319_abnormal_enzyme/_coenzyme | 0.35085861 |
| 88 | MP0005503_abnormal_tendon_morphology | 0.34984298 |
| 89 | MP0003948_abnormal_gas_homeostasis | 0.32953745 |
| 90 | MP0009115_abnormal_fat_cell | 0.32308199 |
| 91 | MP0005451_abnormal_body_composition | 0.31728742 |
| 92 | MP0000230_abnormal_systemic_arterial | 0.28913883 |
| 93 | MP0005423_abnormal_somatic_nervous | 0.27983376 |
| 94 | MP0005332_abnormal_amino_acid | 0.27694838 |
| 95 | MP0008438_abnormal_cutaneous_collagen | 0.24950613 |
| 96 | MP0005165_increased_susceptibility_to | 0.24745083 |
| 97 | * MP0005376_homeostasis/metabolism_phenot | 0.24513153 |
| 98 | MP0005535_abnormal_body_temperature | 0.24425591 |
| 99 | MP0003567_abnormal_fetal_cardiomyocyte | 0.24313095 |
| 100 | MP0005166_decreased_susceptibility_to | 0.24157869 |
| 101 | MP0002118_abnormal_lipid_homeostasis | 0.23757457 |
| 102 | MP0004085_abnormal_heartbeat | 0.23754702 |
| 103 | MP0008770_decreased_survivor_rate | 0.23708828 |
| 104 | MP0001943_abnormal_respiration | 0.22252439 |
| 105 | MP0005187_abnormal_penis_morphology | 0.21903473 |
| 106 | MP0003195_calcinosis | 0.21900938 |
| 107 | MP0004858_abnormal_nervous_system | 0.21119252 |
| 108 | MP0003828_pulmonary_edema | 0.20770994 |
| 109 | MP0006276_abnormal_autonomic_nervous | 0.20614675 |
| 110 | MP0002128_abnormal_blood_circulation | 0.20429010 |
| 111 | MP0001853_heart_inflammation | 0.20128521 |
| 112 | MP0003385_abnormal_body_wall | 0.20036493 |
| 113 | * MP0002066_abnormal_motor_capabilities/c | 0.19943321 |
| 114 | MP0000427_abnormal_hair_cycle | 0.18429797 |
| 115 | MP0002249_abnormal_larynx_morphology | 0.18217735 |
| 116 | MP0010678_abnormal_skin_adnexa | 0.16855292 |
| 117 | MP0002109_abnormal_limb_morphology | 0.16753536 |
| 118 | MP0002932_abnormal_joint_morphology | 0.16587132 |
| 119 | MP0002067_abnormal_sensory_capabilities | 0.14957655 |
| 120 | MP0004197_abnormal_fetal_growth/weight/ | 0.14131140 |
| 121 | MP0003941_abnormal_skin_development | 0.12845397 |
| 122 | MP0002876_abnormal_thyroid_physiology | 0.12395294 |
| 123 | MP0005645_abnormal_hypothalamus_physiol | 0.12226262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 9.92643472 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.55308120 |
| 3 | Nemaline bodies (HP:0003798) | 8.99355362 |
| 4 | Exercise-induced myalgia (HP:0003738) | 8.88259224 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 8.14520640 |
| 6 | Distal arthrogryposis (HP:0005684) | 7.75722838 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 7.36230904 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.90988932 |
| 9 | Myopathic facies (HP:0002058) | 6.83507877 |
| 10 | Round ear (HP:0100830) | 6.45166668 |
| 11 | Ulnar deviation of the wrist (HP:0003049) | 6.33462379 |
| 12 | Calf muscle hypertrophy (HP:0008981) | 6.08697427 |
| 13 | Calcaneovalgus deformity (HP:0001848) | 5.53249106 |
| 14 | Difficulty running (HP:0009046) | 5.42710062 |
| 15 | Myoglobinuria (HP:0002913) | 5.29559044 |
| 16 | Muscle fiber splitting (HP:0003555) | 5.18154049 |
| 17 | Absent phalangeal crease (HP:0006109) | 5.13197805 |
| 18 | Deformed tarsal bones (HP:0008119) | 5.08616245 |
| 19 | Muscle stiffness (HP:0003552) | 4.85355380 |
| 20 | Hyporeflexia of lower limbs (HP:0002600) | 4.75088225 |
| 21 | EMG: myopathic abnormalities (HP:0003458) | 4.51589974 |
| 22 | Rhabdomyolysis (HP:0003201) | 4.47509231 |
| 23 | Increased connective tissue (HP:0009025) | 4.39193418 |
| 24 | Abnormal finger flexion creases (HP:0006143) | 4.29951711 |
| 25 | Myotonia (HP:0002486) | 4.16250276 |
| 26 | Abnormality of the calf musculature (HP:0001430) | 4.03748810 |
| 27 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.81021588 |
| 28 | Subaortic stenosis (HP:0001682) | 3.62001144 |
| 29 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.62001144 |
| 30 | Rimmed vacuoles (HP:0003805) | 3.53806211 |
| 31 | Malignant hyperthermia (HP:0002047) | 3.52266030 |
| 32 | Neck muscle weakness (HP:0000467) | 3.51894319 |
| 33 | Increased variability in muscle fiber diameter (HP:0003557) | 3.39291788 |
| 34 | Abnormality of the calcaneus (HP:0008364) | 3.35166467 |
| 35 | Difficulty climbing stairs (HP:0003551) | 3.29590340 |
| 36 | Frequent falls (HP:0002359) | 3.26079751 |
| 37 | Shoulder girdle muscle weakness (HP:0003547) | 3.25554952 |
| 38 | Pelvic girdle muscle weakness (HP:0003749) | 3.25262100 |
| 39 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.13739459 |
| 40 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.13739459 |
| 41 | Areflexia of lower limbs (HP:0002522) | 3.12197110 |
| 42 | Hyperkalemia (HP:0002153) | 3.03126368 |
| 43 | Asymmetric septal hypertrophy (HP:0001670) | 2.83989461 |
| 44 | Slender build (HP:0001533) | 2.76120801 |
| 45 | Bundle branch block (HP:0011710) | 2.75924576 |
| 46 | Paralysis (HP:0003470) | 2.63268871 |
| 47 | Sudden death (HP:0001699) | 2.55619571 |
| 48 | Fatigable weakness (HP:0003473) | 2.53901065 |
| 49 | Abnormality of the neuromuscular junction (HP:0003398) | 2.53901065 |
| 50 | EMG: neuropathic changes (HP:0003445) | 2.48373559 |
| 51 | Distal lower limb muscle weakness (HP:0009053) | 2.45785972 |
| 52 | Muscular dystrophy (HP:0003560) | 2.36167091 |
| 53 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.27171222 |
| 54 | Hypoplastic ischia (HP:0003175) | 2.22775160 |
| 55 | Limb-girdle muscle weakness (HP:0003325) | 2.22481086 |
| 56 | Generalized muscle weakness (HP:0003324) | 2.22453552 |
| 57 | Metatarsus adductus (HP:0001840) | 2.21634078 |
| 58 | Nonprogressive disorder (HP:0003680) | 2.16337729 |
| 59 | Spinal rigidity (HP:0003306) | 2.16246562 |
| 60 | Bulbar palsy (HP:0001283) | 2.15673143 |
| 61 | Ulnar deviation of finger (HP:0009465) | 2.15445004 |
| 62 | Proximal amyotrophy (HP:0007126) | 2.13697760 |
| 63 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.10936918 |
| 64 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.04598994 |
| 65 | Facial diplegia (HP:0001349) | 2.00872704 |
| 66 | Scapular winging (HP:0003691) | 1.98834531 |
| 67 | Gowers sign (HP:0003391) | 1.95612838 |
| 68 | Abnormality of the foot musculature (HP:0001436) | 1.95059741 |
| 69 | Abnormality of the ischium (HP:0003174) | 1.94697165 |
| 70 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.90721491 |
| 71 | Limb-girdle muscle atrophy (HP:0003797) | 1.90310833 |
| 72 | Distal lower limb amyotrophy (HP:0008944) | 1.87809597 |
| 73 | Weak cry (HP:0001612) | 1.85108154 |
| 74 | Popliteal pterygium (HP:0009756) | 1.84928786 |
| 75 | Progressive muscle weakness (HP:0003323) | 1.80996583 |
| 76 | Foot dorsiflexor weakness (HP:0009027) | 1.80407942 |
| 77 | Achilles tendon contracture (HP:0001771) | 1.79717122 |
| 78 | Waddling gait (HP:0002515) | 1.79341213 |
| 79 | Heart block (HP:0012722) | 1.77485383 |
| 80 | Tarsal synostosis (HP:0008368) | 1.73719166 |
| 81 | Fetal akinesia sequence (HP:0001989) | 1.69014340 |
| 82 | Ragged-red muscle fibers (HP:0003200) | 1.68731480 |
| 83 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.68309247 |
| 84 | Abnormal atrioventricular conduction (HP:0005150) | 1.66841515 |
| 85 | Ventricular tachycardia (HP:0004756) | 1.64843029 |
| 86 | Increased purine levels (HP:0004368) | 1.63406077 |
| 87 | Hyperuricemia (HP:0002149) | 1.63406077 |
| 88 | Abnormality of the Achilles tendon (HP:0005109) | 1.63359792 |
| 89 | Increased density of long bones (HP:0006392) | 1.63054726 |
| 90 | Stridor (HP:0010307) | 1.61215954 |
| 91 | Type 2 muscle fiber atrophy (HP:0003554) | 1.60668210 |
| 92 | Cholelithiasis (HP:0001081) | 1.59459661 |
| 93 | Short palpebral fissure (HP:0012745) | 1.59187435 |
| 94 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.56233138 |
| 95 | Synostosis involving bones of the feet (HP:0009140) | 1.56233138 |
| 96 | Abnormality of potassium homeostasis (HP:0011042) | 1.55927295 |
| 97 | Adducted thumb (HP:0001181) | 1.53945007 |
| 98 | Gout (HP:0001997) | 1.53855321 |
| 99 | Hip contracture (HP:0003273) | 1.52747216 |
| 100 | Limited hip movement (HP:0008800) | 1.51458869 |
| 101 | Increased intramyocellular lipid droplets (HP:0012240) | 1.48983253 |
| 102 | Muscle fiber atrophy (HP:0100295) | 1.48907342 |
| 103 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.48063430 |
| 104 | Oligomenorrhea (HP:0000876) | 1.47838437 |
| 105 | Ventricular arrhythmia (HP:0004308) | 1.47132267 |
| 106 | Congenital hip dislocation (HP:0001374) | 1.43609753 |
| 107 | Exercise intolerance (HP:0003546) | 1.42464382 |
| 108 | Long clavicles (HP:0000890) | 1.41913643 |
| 109 | Lipoatrophy (HP:0100578) | 1.40974855 |
| 110 | Abnormal gallbladder morphology (HP:0012437) | 1.40470906 |
| 111 | Lower limb amyotrophy (HP:0007210) | 1.38305332 |
| 112 | Dilated cardiomyopathy (HP:0001644) | 1.38257371 |
| 113 | Increased muscle lipid content (HP:0009058) | 1.37780276 |
| 114 | Abnormality of placental membranes (HP:0011409) | 1.33340880 |
| 115 | Amniotic constriction ring (HP:0009775) | 1.33340880 |
| 116 | Steppage gait (HP:0003376) | 1.30684260 |
| 117 | Breech presentation (HP:0001623) | 1.22463737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 8.62814117 |
| 2 | TTN | 6.28401088 |
| 3 | PHKG1 | 5.75611053 |
| 4 | PHKG2 | 5.75611053 |
| 5 | NME1 | 4.47897484 |
| 6 | PIK3CG | 3.73395413 |
| 7 | MAP2K3 | 2.98502768 |
| 8 | NEK1 | 2.36385874 |
| 9 | MAP3K7 | 2.15183724 |
| 10 | PINK1 | 2.05121309 |
| 11 | PDK4 | 1.85182105 |
| 12 | PDK3 | 1.85182105 |
| 13 | TRIB3 | 1.75478636 |
| 14 | PIK3CA | 1.70053451 |
| 15 | DMPK | 1.68786626 |
| 16 | MAP2K4 | 1.66958070 |
| 17 | MAPK12 | 1.63078906 |
| 18 | BCKDK | 1.53199360 |
| 19 | MAP2K6 | 1.47147121 |
| 20 | PDK2 | 1.24793096 |
| 21 | MUSK | 1.15939995 |
| 22 | MAP3K3 | 0.96898894 |
| 23 | MARK1 | 0.94909765 |
| 24 | PRKAA2 | 0.91923011 |
| 25 | NEK9 | 0.90766369 |
| 26 | MAPKAPK3 | 0.86280882 |
| 27 | PRKAA1 | 0.84891420 |
| 28 | STK24 | 0.81266447 |
| 29 | TAOK2 | 0.78890382 |
| 30 | ERBB3 | 0.75268129 |
| 31 | TRPM7 | 0.74052518 |
| 32 | ZAK | 0.68771299 |
| 33 | MAP3K13 | 0.65116290 |
| 34 | MAPK11 | 0.64000030 |
| 35 | PKN2 | 0.60797815 |
| 36 | MAP3K11 | 0.59002544 |
| 37 | CAMK4 | 0.58553568 |
| 38 | SIK1 | 0.55924968 |
| 39 | CAMK2G | 0.55100618 |
| 40 | AKT2 | 0.54586229 |
| 41 | TAOK1 | 0.52229044 |
| 42 | EPHB1 | 0.47347521 |
| 43 | RIPK1 | 0.45300070 |
| 44 | LIMK1 | 0.44504748 |
| 45 | ILK | 0.42936316 |
| 46 | CAMK1 | 0.40661324 |
| 47 | CAMK2B | 0.39549263 |
| 48 | CAMK2A | 0.39470091 |
| 49 | PTK6 | 0.38127601 |
| 50 | EEF2K | 0.33801614 |
| 51 | MAP3K6 | 0.33379383 |
| 52 | SGK1 | 0.33041485 |
| 53 | TBK1 | 0.30589829 |
| 54 | SGK2 | 0.30300331 |
| 55 | KSR2 | 0.28560382 |
| 56 | MAP3K5 | 0.28427561 |
| 57 | PRKACB | 0.27572588 |
| 58 | PKN1 | 0.27053134 |
| 59 | PRKG1 | 0.26817052 |
| 60 | RPS6KB1 | 0.26382326 |
| 61 | MAPK13 | 0.26233798 |
| 62 | MAP3K1 | 0.24871882 |
| 63 | RPS6KA3 | 0.23965967 |
| 64 | MAP3K10 | 0.23560156 |
| 65 | CDK19 | 0.21675351 |
| 66 | MAPK4 | 0.20155132 |
| 67 | MAPK7 | 0.19493354 |
| 68 | PRPF4B | 0.19273834 |
| 69 | ARAF | 0.18959386 |
| 70 | PRKACA | 0.18705838 |
| 71 | MARK2 | 0.17825816 |
| 72 | ROCK1 | 0.16607786 |
| 73 | PDPK1 | 0.15374716 |
| 74 | CAMK1G | 0.15365679 |
| 75 | TIE1 | 0.15350550 |
| 76 | INSRR | 0.14943843 |
| 77 | TYK2 | 0.14895474 |
| 78 | DAPK2 | 0.14280967 |
| 79 | PRKD1 | 0.13359224 |
| 80 | MAP2K1 | 0.13217313 |
| 81 | PDK1 | 0.13028486 |
| 82 | LATS1 | 0.12268472 |
| 83 | RPS6KL1 | 0.12172837 |
| 84 | RPS6KC1 | 0.12172837 |
| 85 | SGK494 | 0.12163331 |
| 86 | SGK223 | 0.12163331 |
| 87 | PAK6 | 0.10350446 |
| 88 | TGFBR2 | 0.09922320 |
| 89 | RAF1 | 0.09629452 |
| 90 | ZAP70 | 0.09619730 |
| 91 | MOS | 0.08715368 |
| 92 | RPS6KA6 | 0.08365323 |
| 93 | RPS6KA1 | 0.07831281 |
| 94 | LATS2 | 0.07238951 |
| 95 | MARK3 | 0.07145899 |
| 96 | DYRK1B | 0.06949192 |
| 97 | FGFR1 | 0.06861337 |
| 98 | BRAF | 0.06499628 |
| 99 | BMX | 0.06408109 |
| 100 | LRRK2 | 0.05628406 |
| 101 | NLK | 0.05574219 |
| 102 | PRKACG | 0.04858192 |
| 103 | MAPK10 | 0.03992640 |
| 104 | MST1R | 0.03310775 |
| 105 | ERN1 | 0.03189265 |
| 106 | SGK3 | 0.03159724 |
| 107 | GSK3A | 0.03064042 |
| 108 | CAMK2D | 0.03004359 |
| 109 | JAK2 | 0.02904304 |
| 110 | MTOR | 0.02532183 |
| 111 | GSK3B | 0.02029543 |
| 112 | STK11 | 0.01925539 |
| 113 | CSNK1D | 0.01834558 |
| 114 | ICK | 0.01774004 |
| 115 | CCNB1 | 0.01579656 |
| 116 | PTK2B | 0.01481803 |
| 117 | MAPK8 | 0.01292706 |
| 118 | KSR1 | 0.00841652 |
| 119 | RET | -0.0322443 |
| 120 | MAPK9 | -0.0254948 |
| 121 | RPS6KB2 | -0.0246570 |
| 122 | FER | -0.0208607 |
| 123 | PRKDC | -0.0188632 |
| 124 | ROCK2 | -0.0183257 |
| 125 | RPS6KA2 | -0.0142896 |
| 126 | FLT3 | -0.0035921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.24149910 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.22611635 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.70949991 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.63199897 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.34540169 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.26457220 |
| 7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 3.17876448 |
| 8 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.48594000 |
| 9 | Circadian rhythm_Homo sapiens_hsa04710 | 2.45691430 |
| 10 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.36131263 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.33161178 |
| 12 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.32387629 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.21447537 |
| 14 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.20888171 |
| 15 | Insulin resistance_Homo sapiens_hsa04931 | 2.18347219 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.90764289 |
| 17 | Galactose metabolism_Homo sapiens_hsa00052 | 1.90009965 |
| 18 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.81913013 |
| 19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.76228650 |
| 20 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.75743360 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.75463075 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.70776146 |
| 23 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.67556199 |
| 24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.63003237 |
| 25 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.60786192 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.55703029 |
| 27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.54910778 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41827142 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.40787295 |
| 30 | Tight junction_Homo sapiens_hsa04530 | 1.37657145 |
| 31 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.33631852 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.31685389 |
| 33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.30843094 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.30760278 |
| 35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.28345055 |
| 36 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.25976425 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.24099809 |
| 38 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.10580576 |
| 39 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.06527113 |
| 40 | Focal adhesion_Homo sapiens_hsa04510 | 1.03438572 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.02278552 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.99135060 |
| 43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.98748355 |
| 44 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.96522842 |
| 45 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.94129386 |
| 46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.93509934 |
| 47 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.86686896 |
| 48 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.78914678 |
| 49 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.78603916 |
| 50 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75585654 |
| 51 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73753844 |
| 52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72033658 |
| 53 | Renin secretion_Homo sapiens_hsa04924 | 0.67531123 |
| 54 | Huntingtons disease_Homo sapiens_hsa05016 | 0.66703785 |
| 55 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64889097 |
| 56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61192850 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.55795302 |
| 58 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.52911899 |
| 59 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52423912 |
| 60 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.51475802 |
| 61 | Insulin secretion_Homo sapiens_hsa04911 | 0.49856243 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48203799 |
| 63 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45637361 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44461398 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44265165 |
| 66 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44098479 |
| 67 | Salivary secretion_Homo sapiens_hsa04970 | 0.42124761 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.41799140 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 0.38293672 |
| 70 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.36426582 |
| 71 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35698782 |
| 72 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.34111932 |
| 73 | Long-term depression_Homo sapiens_hsa04730 | 0.33214943 |
| 74 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.29870838 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.29838104 |
| 76 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.29788209 |
| 77 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.29167607 |
| 78 | Glioma_Homo sapiens_hsa05214 | 0.27177694 |
| 79 | Histidine metabolism_Homo sapiens_hsa00340 | 0.25061214 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.24934114 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24882211 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24840732 |
| 83 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.22624967 |
| 84 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.22346963 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.19319081 |
| 86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.18112148 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.17026755 |
| 88 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.16865032 |
| 89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.16577545 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.15955851 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.14511469 |
| 92 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.13628602 |
| 93 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.12092174 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.11756485 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.11533724 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.11511853 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.10861967 |
| 98 | Peroxisome_Homo sapiens_hsa04146 | 0.10846378 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.10012714 |
| 100 | Long-term potentiation_Homo sapiens_hsa04720 | 0.09996580 |
| 101 | Circadian entrainment_Homo sapiens_hsa04713 | 0.09816506 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.09600635 |
| 103 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.09377487 |
| 104 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.09257076 |
| 105 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.09178212 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.09010022 |
| 107 | Melanogenesis_Homo sapiens_hsa04916 | 0.08502106 |
| 108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.08474278 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08230109 |
| 110 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.07751073 |
| 111 | Bile secretion_Homo sapiens_hsa04976 | 0.07011637 |
| 112 | Olfactory transduction_Homo sapiens_hsa04740 | 0.06865177 |
| 113 | Sulfur relay system_Homo sapiens_hsa04122 | 0.06330045 |
| 114 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.05793545 |
| 115 | Purine metabolism_Homo sapiens_hsa00230 | 0.05613708 |
| 116 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.05419163 |
| 117 | ABC transporters_Homo sapiens_hsa02010 | 0.03592879 |

